Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.)

Scopus

Scopus profile and journal metrics

This journal is indexed in Scopus. Use these metrics for a quick publishing snapshot, then open the Scopus page for the authoritative profile.

Scopus
Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) Indexed in Scopus since 2022
CiteScore 1.0
Indexed since 2022
First decision 7 Days
Submission to acceptance 45 Days
Acceptance to publication 14 Days
Acceptance rate 8%

SCImago

SCImago Journal Rank preview

Use SCImago when you want a quick visual view of the journal ranking profile and external discoverability signals.

Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) SCImago Journal & Country Rank

DOAJ

Directory of Open Access Journals listing

The DOAJ record is useful for readers, librarians, and authors who want a direct open-access directory entry for the journal.

DOAJ
Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) Open directory record
Original full research article

Illness Perception in Patients with Thalassemia in Nablus, Palestine: A Pilot study

Published
2017-12-14
Pages
7 - 13
Full text

Keywords

  • Palestine;
  • blood
  • Perception
  • Thalassemia;
  • Questionnaire;
  • Brief-Illness

Abstract

Thalassemia is a hemoglobinopathy which is results from a gene mutation in α or β chain. It has the preeminent prevalence in Mediterranean, tropical areas and regions near the equator. Thalassemia is one of the most prevalent genetic blood disorders in the world. Research pertaining to patient perception of thalassemia is limited in Palestine. Our study is the first one nationwide that aims to assess the perceptions and attitudes toward thalassemia and thalassemia treatment. A cross-sectional, non-interventional, descriptive study design was used. A convenient sample of 113 thalassemic patients attending the specialty clinic at Al-Watani hospital, Nablus, Palestine was included. We used a previously published Brief-Illness Perception Questionnaire (B-IPQ) version to achieve the objectives of the study. A total of 113 thalassemic patients aged 12-70 (average 21.0±9.5 years) were recruited, 51.3% were females, and they have been diagnosed since 19.4± 7.4 years. A bit less than half (44.2%) had college education; the rest had high school or less level. The largest category (55.8%) live in villages, 57.5% of them had a consanguineous marriage, yet almost all (98.2%) of the participants did not have any other diseases. As for the perception aspects, participants believe their disease as chronic, and that the treatment can control their disease to a significant extent (treatment control) (median = 10 for both). As for personal control, it was high with a median of 8, and the same value was also achieved for understanding the disease. The remaining components of the B-IPQ were found to be 3 indicating a low score Data indicated that the participants perceive their disease as chronic with treatment being able to control. They also believe that they have some control over the disease, and that it has minimal effect on their quality of life. More steps should be taken to focus on the psychological aspects of this disease, and more education is needed to prevent its occurrence, especially those related to consanguineous marriage.

Article history

Received
2017-09-16
Accepted
2017-12-14
بحث أصيل كامل

Illness Perception in Patients with Thalassemia in Nablus, Palestine: A Pilot study

Published
2017-12-14
الصفحات
7 - 13
البحث كاملا

الكلمات الإفتتاحية

  • Palestine;
  • blood
  • Perception
  • Thalassemia;
  • Questionnaire;
  • Brief-Illness

الملخص

Thalassemia is a hemoglobinopathy which is results from a gene mutation in α or β chain. It has the preeminent prevalence in Mediterranean, tropical areas and regions near the equator. Thalassemia is one of the most prevalent genetic blood disorders in the world. Research pertaining to patient perception of thalassemia is limited in Palestine. Our study is the first one nationwide that aims to assess the perceptions and attitudes toward thalassemia and thalassemia treatment. A cross-sectional, non-interventional, descriptive study design was used. A convenient sample of 113 thalassemic patients attending the specialty clinic at Al-Watani hospital, Nablus, Palestine was included. We used a previously published Brief-Illness Perception Questionnaire (B-IPQ) version to achieve the objectives of the study. A total of 113 thalassemic patients aged 12-70 (average 21.0±9.5 years) were recruited, 51.3% were females, and they have been diagnosed since 19.4± 7.4 years. A bit less than half (44.2%) had college education; the rest had high school or less level. The largest category (55.8%) live in villages, 57.5% of them had a consanguineous marriage, yet almost all (98.2%) of the participants did not have any other diseases. As for the perception aspects, participants believe their disease as chronic, and that the treatment can control their disease to a significant extent (treatment control) (median = 10 for both). As for personal control, it was high with a median of 8, and the same value was also achieved for understanding the disease. The remaining components of the B-IPQ were found to be 3 indicating a low score Data indicated that the participants perceive their disease as chronic with treatment being able to control. They also believe that they have some control over the disease, and that it has minimal effect on their quality of life. More steps should be taken to focus on the psychological aspects of this disease, and more education is needed to prevent its occurrence, especially those related to consanguineous marriage.

Article history

تاريخ التسليم
2017-09-16
تاريخ القبول
2017-12-14